ARTERIAL AND VENOUS THROMBOSIS–TWO FACES OF THE SAME DISEASE. CASE REPORT

  • Minerva Codruta BADESCU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Liliana GHEORGHE “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Nicoleta DIMA “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Ana Roxana GANCEANU RUSU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Minela Aida MARANDUCA “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Manuela CIOCOIU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • C. REZUS “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

ARTERIAL AND VENOUS THROMBOSIS-TWO FACES OF THE SAME DISEASE. CASE REPORT (Abstract): Abnormal activation of the coagulation cascade in cancer patients leads to arterial and venous thrombotic events. If the link between venous thromboembolism and malignancy has long been known, cancer-related stroke is a newly recognized entity. We present the case of a 90-year-old woman who developed two concurrent ischemic strokes in the right posterior cerebral artery territory and deep vein thrombosis of the left lower limb, cascade of events that led to the diagnosis of a cancer. We highlight some of the particularities of cancer-related stroke to raise awareness upon this complication that leads to increased morbidity and mortality in cancer patients. We suggest that special attention should be paid to patients with concomitant thrombotic events in different vascular areas because a systemic underlying substrate may be involved.

Author Biographies

Minerva Codruta BADESCU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (I)
“Sf. Spiridon” County Clinical Emergency Hospital, Iasi

Liliana GHEORGHE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Surgery (II)
Department of Morpho-Functional Sciences (II)
“Sf. Spiridon” County Clinical Emergency Hospital, Iasi

Nicoleta DIMA, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (I)
“Sf. Spiridon” County Clinical Emergency Hospital, Iasi

Ana Roxana GANCEANU RUSU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (I)

Minela Aida MARANDUCA, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Morpho-Functional Sciences (II)
“Sf. Spiridon” County Clinical Emergency Hospital, Iasi

Manuela CIOCOIU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Morpho-Functional Sciences (II)

C. REZUS, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (I)
“Sf. Spiridon” County Clinical Emergency Hospital, Iasi

References

1. Lee MJ, Chung JW, Ahn MJ, et al. Hypercoagulability and mortality of patients with stroke and active cancer: The OASIS-CANCER Study. JoS 2017; 19(1): 77-87.
2. Field TS, Hill MD. Prevention of deep vein thrombosis and pulmonary embolism in patients with stroke. Clin Appl Thromb Hemost 2012; 18(1): 5-19.
3. André C, de Freitas GR, Fukujima MM. Prevention of deep venous thrombosis and pulmonary embo-lism following stroke: a systematic review of published articles. Eur J Neurol 2007; 14(1): 21-32.
4. Short N, Connors J. New oral anticoagulants and the cancer patient. Oncologist 2014; 19: 82-93.
5. Rodriguez A, Gonik A, Zhou H, Leiserowitz G, White R. Venous thromboembolism in uterine cancer. Int J Gynecol Cancer 2011; 21: 870-876.
6. Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006; 166(4): 458-464.
7. Kearon C, Akl E, Ornelas J, et al. Antithrombotic therapy for VTE disease CHEST guideline and expert panel report. CHEST 2016; 149(2): 315-352.
8. Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding compli-cations during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100(10): 3484-3488.
9. Dearborn JL, Urrutia VC, Zeiler SR. Stroke and cancer - a complicated relationship. J Neurol Transl Neurosci 2014; 2(1): 1039-1054.
10. Haliga R, Drug VL, Negru D, Ambarus V, Neghina I, Sorodoc L. Unmasking a young adult migratory deep venous thrombosis. Case report. Rev Med Chir Soc Med Nat Iasi 2013; 117(4): 924-928.
11. Perez-Lazaro C, Santos S, Morales-Rull JL, Garcés-Redondo M, Del Corral-Beamonte E, Fabre-Pi O, et al. Stroke as the first manifestation of a concealed pancreatic neoplasia. Rev Neurol 2004; 38: 332-335.
12. Borowski A, Ghodsizad A, Gams E. Stroke as a first manifestation of ovarian cancer. J Neurooncol 2005; 71(3): 267-269.
13. Kwon HM, Kang BS, Yoon BW. Stroke as the first manifestation of concealed cancer. J Neurol Sci 2007; 258(1-2): 80-83.
14. Kim SJ, Park JH, Lee MJ, Park YG, Ahn MJ, Bang OY. Clues to occult cancer in patients with is-chemic stroke. PLoS One 2012; 7(9): e44959.
15. Hong CT, Tsai LK, Jeng JS. Patterns of acute cerebral infarcts in patients with active malignancy using diffusion-weighted imaging. Cerebrovasc Dis 2009; 28(4): 411-416.
16. Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 2002; 4(6): 465-473.
17. Jander S, Sitzer M, Wendt A, et al. Expression of tissue factor in high-grade carotid artery stenosis: association with plaque destabilization. Stroke 2001; 32(4): 850-854.
18. Seok JM, Kim SG, Kim JW, et al. Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol 2010; 68(2): 213-219.
19. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008; 111(10): 4902-4907.
Published
2018-10-03
Section
INTERNAL MEDICINE - PEDIATRICS